Amrize vs Owens Corning
AMRZ and OC side by side, both in materials. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AMRZ and OC compare
Amrize is the larger company, worth 2.4 times as much as Owens Corning ($22.6B against $9.6B).
Amrize grew revenue faster over the last twelve months (3.5% versus −7.2% for Owens Corning).
Amrize keeps more of each dollar of sales as profit, with a net margin of 10.2% compared with −6.8% at Owens Corning.
Both pay dividends: Amrize yields 1.6% and Owens Corning 2.6%.
Amrize scores higher on the StockData Score (10 against 6 for Owens Corning), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AMRZ | OC |
|---|---|---|
| Size and price | ||
| Market cap | $22.6B | $9.6B |
| Share price | $41.38 | $121.15 |
| Change, 1 year | −21.7% | −2.8% |
| Change, 5 years | – | 27.0% |
| Beta (5Y) | 0.73 | 1.25 |
| Employees | 19K | 25K |
| StockData Score | ||
| Total score | 10 (better) | 6 |
| Valuation score | 3 (better) | 0 |
| Growth score | 1 | 1 |
| Performance score | 2 (better) | 0 |
| Health score | 3 (better) | 2 |
| Dividend score | 1 | 3 (better) |
| Valuation | ||
| P/E | 18.2× | – |
| P/S | 1.8× | 1.0× (better) |
| P/B | 1.8× (better) | 2.5× |
| EV/EBITDA | 10.2× (better) | 17.9× |
| P/FCF | 21.0× | 10.7× (better) |
| FCF yield | 4.8% | 9.4% (better) |
| Fair value | $47.20 | $76.61 |
| Margin of safety | 12.3% (better) | −58.1% |
| Growth | ||
| Revenue growth (TTM) | 3.5% (better) | −7.2% |
| Revenue growth, 5Y average | – | 7.4% |
| Net income growth (TTM) | 8.3% (better) | −302% |
| EPS growth (TTM) | 8.6% (better) | −311% |
| Profitability | ||
| Gross margin | 24.8% | 26.0% (better) |
| Operating margin | 15.5% (better) | 0.51% |
| Net margin | 10.2% (better) | −6.8% |
| FCF margin | 8.8% | 9.1% (better) |
| Return on equity | 9.8% (better) | −15.0% |
| Return on invested capital | 9.7% (better) | 0.43% |
| Financial health | ||
| Debt / equity | 0.46 (better) | 1.14 |
| Net debt / EBITDA | 2.00 (better) | 5.28 |
| Interest coverage | 5.3× (better) | 0.1× |
| Current ratio | 1.07 | 1.16 (better) |
| Altman Z-score | 2.03 (better) | 1.97 |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 1.6% | 2.6% (better) |
| Years of dividend growth | – | 12 |
| Dividend growth, 5Y average | – | 23.9% |
| Buyback yield | – | 7.1% |
| Shareholder yield | 1.6% | 9.7% (better) |
| Ownership | ||
| Held by institutions | 47.1% | 106% |
| Held by insiders | 7.4% | 1.3% |
| Insider net buying, 12 months | $10.2M (better) | −$447K |
| Superinvestors holding | 3 (better) | 2 |
| Short interest, % of float | 2.2% | 3.1% |
Go deeper
- AMRZ stock overview
- AMRZ income statement
- AMRZ valuation and score
- OC stock overview
- OC income statement
- OC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.